WASHINGTON – Two late-stage COVID-19 medical trials have been paused in the space of 24 hours over potential safety concerns, the latest setbacks to scientists in the long fight against the pandemic.
US pharmaceutical firm Eli Lilly on Tuesday suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalized patients over an unspecified incident.
A day earlier, the American pharmaceutical giant Johnson & Johnson temporarily halted its Phase 3 COVID-19 vaccine trial due to an unexplained illness in a study participant.
J&J’s research head Mathai Mammen said it was a “temporary pause” that could be unrelated to their drug. (AFP)
